Evidence map›Paper›PMID 29888258›Full record

ArticleBioMed research international2018

In Vitro Antifungal Susceptibility of

Saeid Mahdavi Omran, Maryam Rezaei Dastjerdi, Maryam Zuashkiani, Vahid Moqarabzadeh, Mojtaba Taghizadeh-Armaki

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Microorganisms · 2025
    Article
  2. Article
  3. Prevalence and drug susceptibility of clinicalOne health (Amsterdam, Netherlands) · 2024
    Article
  4. Article
  5. Antifungal Resistance of ClinicalIranian journal of public health · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Effect ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Saeid Mahdavi OmranInfectious Diseases and Tropical Medicine Research Center, Department of Medical Parasitology and Mycology, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0003-1300-8987
Maryam Rezaei DastjerdiDepartment of Prosthodontics, Faculty of Dentistry, Babol University of Medical Sciences, Babol, Iran.
Maryam ZuashkianiDepartment of Prosthodontics, Faculty of Dentistry, Babol University of Medical Sciences, Babol, Iran.
Vahid MoqarabzadehDepartment of Biostatistics, Faculty of Health, Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Mojtaba Taghizadeh-ArmakiDepartment of Medical Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.ORCID 0000-0003-1811-5829
Babol University of Medical Sciences · IRMazandaran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsA total of 134

resultsOverall, DISCUSSION: Our study showed that

Indexed as

Antifungal AgentsCandida albicansFemaleHumansIranMaleMicrobial Sensitivity TestsStomatitis, DentureAntifungal Agents

Identifiers

PMID29888258
PMCPMC5977002
OpenAlexW2804564262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.